Benitec Biopharma Quick Ratio 2014-2022 | BNTC
Historical quick ratio values for Benitec Biopharma (BNTC) over the last 10 years.
| Benitec Biopharma Quick Ratio Historical Data |
| Date |
Current Assets - Inventory |
Current Liabilities |
Quick Ratio |
| 2022-09-30 |
$0.00B |
$0.00B |
0.00 |
| 2022-06-30 |
$0.00B |
$0.00B |
0.00 |
| 2022-03-31 |
$0.00B |
$0.00B |
0.00 |
| 2021-12-31 |
$0.00B |
$0.00B |
0.00 |
| 2021-09-30 |
$0.00B |
$0.00B |
0.00 |
| 2021-06-30 |
$0.00B |
$0.00B |
0.00 |
| 2021-03-31 |
$0.00B |
$0.00B |
0.00 |
| 2020-12-31 |
$0.00B |
$0.00B |
0.00 |
| 2020-09-30 |
$0.00B |
$0.00B |
0.00 |
| 2020-06-30 |
$0.00B |
$0.00B |
0.00 |
| 2020-03-31 |
$0.00B |
|
0.00 |
| 2019-12-31 |
$0.00B |
$0.00B |
0.00 |
| 2019-09-30 |
$0.00B |
|
0.00 |
| 2017-09-30 |
$0.00B |
$0.00B |
0.00 |
| 2016-09-30 |
$0.00B |
$0.00B |
0.00 |
| 2016-06-30 |
$0.00B |
$0.00B |
0.00 |
| 2016-03-31 |
$0.00B |
$0.00B |
0.00 |
| 2015-12-31 |
$0.00B |
$0.00B |
0.00 |
| 2015-06-30 |
$0.00B |
$0.00B |
0.00 |
| 2014-12-31 |
$0.00B |
$0.00B |
0.00 |
| 2014-06-30 |
$0.00B |
$0.00B |
0.00 |
| 2013-06-30 |
$0.00B |
$0.00B |
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.006B |
$0.000B |
|
Benitec Biopharma Limited is a biotechnology company which developed a patented gene silencing technology delivered by gene therapy called DNA directed RNA interference. The company is developing ddRNAi-based therapeutics for chronic and life-threatening human conditions including hepatitis C and B, drug resistant lung cancer and wet age-related macular degeneration. Benitec Biopharma Limited is based in Sydney, Australia.
|
